Xu Xinmei, et al.
Biomedicine & Pharmacotherapy, 2021
Abstract
The increased incidence of metabolic diseases (e.g., diabetes and obesity) has seriously affected human health and life safety worldwide. It is of great significance to find effective drugs from natural compounds to treat metabolic diseases. Berberine (BBR), an important quaternary benzylisoquinoline alkaloid, exists in many traditional medicinal plants. In recent years, BBR has received widespread attention due to its good potential in the treatment of metabolic diseases. In order to promote the basic research and clinical application of BBR, this review provides a timely and comprehensive summary of the pharmacological and clinical advances of BBR in the treatment of five metabolic diseases, including type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease, hyperlipidemia, and gout. Both animal and clinical studies have proved that BBR has good therapeutic effects on these five metabolic diseases. The therapeutic effects of BBR are based on regulating various metabolic aspects and pathophysiological procedures. For example, it can promote insulin secretion, improve insulin resistance, inhibit lipogenesis, alleviate adipose tissue fibrosis, reduce hepatic steatosis, and improve gut microbiota disorders. Collectively, BBR may be a good and promising drug candidate for the treatment of metabolic diseases. More studies, especially clinical trials, are needed to further confirm its molecular mechanisms and targets. In addition, large-scale, long-term and multi-center clinical trials are necessary to evaluate the efficacy and safety of BBR in the treatment of these metabolic diseases.
Keywords
Berberine; Clinical data; Diabetes; Metabolic disease; Obesity.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
| PMID: | 33186794 |
|---|---|
| DOI: | 10.1016/j.biopha.2020.110984 |
| Category: | Digestive Health |
The best supplements with Berberine in Digestive Health category:
- Detoxyn - Most of the human population are carriers of at least one parasite. It contains among others: Berberine.
Articles similar to "Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence."
- The role of Berberine in Digestive Health: Berberine and Its Role in Chronic Disease. (Berberine is a quaternary ammonium salt from the protoberberine group of isoquinoline alkaloids...)
- The impact of Berberine on Digestive Health: Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders. (Berberine is a quaternary ammonium salt from the protoberberine group of isoquinoline alkaloids found in such plants as gender Berberis...)
- The significance of Berberine for Digestive Health: Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. (The antibacterial activity of extract and isolated major alkaloids (berberine, beta-hydrastine, canadine and canadaline) of Hydrastis canadensis L...)
Previous article
Next article
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.